Board of Directors

Board of Directors since 2019. Independent of the company and significant shareholders.

Education:Bachelor of Business Administration degree in Accounting from the Catholic University of Brazil. Owner/President Management program in General Management at Harvard Business School.

Experience:Mr. Calado has, among others, served as a member of the Board of Directors of Aveleda S.A. and OutSystems S.A. He has been President of iMAX Diagnostic Imaging Business Unit, Vice President of Hovione S.A., Vice President and CFO of Hovione S.A. Additionally, Mr. Calado has held various positions at PepsiCo, Inc. including Vice President and CFO of PepsiCo Foods International.

Other current positions of trust:Mr. Calado is the President of Gamcal LLC, a member of the Board of Directors of Wygroup, S.A, Chairman of the Supervisory Board of OutSystems S.A. and the Lead Director of the Board of Directors of HNI Corporation.

Holdings in the company: 101,386 shares and 380,000 stock options, entitling to same amount of shares in the company.

Born 1957. Danish citizen. Member of the Board of Directors since 2019. Independent of the company and significant shareholders.

Education: Bachelor of Science degree in biochemical engineering from the Danish Technical University.

Experience: Mr. Laustsen has, among others, served as Chief Manufacturing Officer of Symphogen A/S, Chief Science Officer and member of the Board of Directors of CMC Biologics A/S (now AGC Biologics A/S), CEO of CMC Biologics A/S and CEO of Bactolife A/S.

Other current positions of trust: Mr. Laustsen is member of the Board of Directors of Bactolife A/S, Bioneer ApS, Synklino ApS and VenomAid ApS.

Holdings in the company: 50,308 shares and 300,000 stock options, entitling to same amount of shares in the company.

Chief Financial Officer, born 1971. Finnish citizen. CFO and a member of the Management Team since 2018. Member of the Board of Directors since 2015.

Education: Bachelor of Science degree in economics from Hanken School of Economics in Helsinki.

Experience: Mr. Hæggström has more than 20 years’ experience within finance and investing. Prior roles include positions at Alfred Berg, BNP Paribas, Nordea and SEB.

Other current positions of trust: [-]

Holdings in the company: 749,275 shares and 790,000 stock options, entitling to same amount of shares in the company.

Born 1959. US and Irish citizen. Member of the Board of Directors since 2021. Independent of the company and significant shareholders.

Education:Master of Business Administration from Fairleigh Dickinson University (US) and Bachelor of Science from Montclair State University (US).

Experience:Ms. Thoma has, among others, served as President and CEO of SPI Pharma Inc, COO and President Microbial Control of Lonza AG and various leadership positions in the Pharmaceutical Ingredients business of BASF Corp.

Other current positions of trust:Ms. Thoma serves as independent director on the boards of ANI Pharmaceuticals Inc., Avid Bioservices Inc. and Pharmathen S.A. Jeanne has served two four-year terms on the Board of Directors for DCAT (Drug, Chemical & Associated Technologies Association, Inc.).

Holdings in the company: 50,308 shares 38,630 stock options, entitling to same amount of shares in the company.